PharmaShots | Incisive News in 3 Shots

Subscribe Now

blood-lipid disorders

AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M

AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M

December 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us